Table 2 of Cehofski, Mol Vis 2024; 30:17-35.


Table 2. Samples for validation by ELISA.

Various DME ELISA Control P-value
Number of samples 15 8  
Patients 15 7  
Age (years) 65.2±15.1 71.0±9.3 0.32
Sex (M/F) 9/6 4/4  
BCVA (logMAR) 0.44±0.28    
Central subfield thickness (µm) 384.5±161.9    
Mild non-proliferative diabetic retinopathy (n) 2    
Moderate non-proliferative diabetic retinopathy (n) 4    
Severe non-proliferative diabetic retinopathy (n) 4    
Proliferative diabetic retinopathy (n) 5    
HbA1c (%) 7.9±1.82    
Hypertension (n) 10 3 0.22
Hyperlipidemia (n) 5 0 0.12
Oral treatment (n) 14    
Oral treatment and insulin (n) 4    
Insulin, no oral treatment (n) 0    
Creatinin (mg/dl) 1.31±0.95 0.82±0.12 0.11